Lataa...
Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice
This article considers the use of pretest probability in non-small cell lung cancer (NSCLC) and how its use in EGFR testing has helped establish clinical guidelines on selecting patients for EGFR testing. With an ever-increasing number of molecular abnormalities being identified and often limited ti...
Tallennettuna:
| Julkaisussa: | Ther Adv Med Oncol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5455881/ https://ncbi.nlm.nih.gov/pubmed/28607579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017704329 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|